BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26992242)

  • 1. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
    Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
    Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
    Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
    J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus.
    Mehrad M; Carpenter DH; Chernock RD; Wang H; Ma XJ; Luo Y; Luo J; Lewis JS; El-Mofty SK
    Am J Surg Pathol; 2013 Sep; 37(9):1349-56. PubMed ID: 23797720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
    Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.
    Jacobi C; Ayx I; Fritsche K; Piontek G; Hoffmann D; Weirich G; Knopf A
    Oncotarget; 2015 Feb; 6(5):3462-70. PubMed ID: 25739121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
    Xu B; Ghossein R; Lane J; Lin O; Katabi N
    Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.
    Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS
    Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
    Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
    Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.